More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs
Quick Read
Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price
Quick Read
Setting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries according to a new study by researchers at Johns Hopkins, including our Michael DiStefano
Quick Read
When a Treatment Costs $450,000 or More, It Had Better WorkApril 24, 2019 |
Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves
Quick Read
Use a ‘Greener’ Inhaler If You Can, Patients ToldApril 9, 2019 |
Around 70% of inhalers used in the UK are the types that have high levels of greenhouse gases – compared to around 10% in Sweden
Quick Read
OverprescribedApril 3, 2019 |
High cost isn’t America’s only drug problem. The pharmaceutical industry has followed a brilliant two-pronged strategy to maximize its profits: raise prices and increase consumption of medications
Quick Read
For decades, the Sackler family has generously supported museums worldwide. But now some favorite Sackler charities are reconsidering whether they want the money at all, and several have already rejected any future gifts, concluding that some family members’ ties to the opioid crisis outweighed the benefits
Quick Read
Why Are There Drug Shortages in the US?March 6, 2019 |
A look at why some families dealing with serious illnesses are having to put treatment on hold over prescription drug shortages – with comments from our Yoram Unguru
Quick Read